Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE.
Zandee WT, Feelders RA, Smit Duijzentkunst DA, Hofland J, Metselaar RM, Oldenburg RA, van Linge A, Kam BLR, Teunissen JJM, Korpershoek E, Hendriks JM, Abusaris H, Slagter C, Franssen GJH, Brabander T, De Herder WW.
Zandee WT, et al. Among authors: brabander t.
Eur J Endocrinol. 2019 Jul;181(1):45-53. doi: 10.1530/EJE-18-0901.
Eur J Endocrinol. 2019.
PMID: 31067510